Pyoderma gangrenosum in a patient with systemic sclerosis

Journal of Rheumatology

Volumn 39, Issue 1, 2012, Pages 197-

  Feld, Joy ^a   Bergman, Reuven ^b   Weltfriend, Sara ^b   Zisman, Devy ^a  

^a CARMEL MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; CREATINE KINASE; CYCLOSPORIN; DILTIAZEM; ENALAPRIL; GENTAMICIN; GLUCOCORTICOID; GLYCERYL TRINITRATE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; OMEPRAZOLE; PREDNISONE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; DEBRIDEMENT; DRUG MEGADOSE; FEMALE; HUMAN; LABORATORY TEST; LETTER; MONOTHERAPY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SEROLOGY; SKIN BIOPSY; SKIN TRANSPLANTATION; SKIN ULCER; SYSTEMIC SCLEROSIS;

FEMALE; HUMANS; MIDDLE AGED; PYODERMA GANGRENOSUM; SCLERODERMA, SYSTEMIC; SKIN;

EID: 84855391034     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110479     Document Type: Letter

References (5)

1. Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ 2006;333:181-4. (Pubitemid 44406745)
2. Herrero JE, Mascaró JM Jr, Llambrich A, Herrero C. Sarcoidosis and pyoderma gangrenosum: an exceptional association. The role of trauma and immunosuppressive agents. J Eur Acad Dermatol Venereol 2005;19:97-9. (Pubitemid 40268150)
3. Hod T, Lazarov A, Levy Y. A huge pyoderma gangrenosum-like lesion as a presenting sign of antiphospholipid antibody syndrome. J Rheumatol 2009;36:7:1557-8.
4. Fujikura M, Ohtsuka T, Oyamada Y. Systemic sclerosis in association with peristomal pyoderma gangrenosum. Br J Dermatol 2007;157:609-35.
5. Karimifar M, Salesi M. Scleroderma and pyoderma gangrenosum. Int J Med Sci 2010;2:318-21.